A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Therapeutics

• Publication date

  2005-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.CLINTHERA.2005.06.012PMID 16117986
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Short-Course Antimicrobial Therapy of Respiratory Tract Infections

  2012cited by this paper
• Otitis media

  2005cited by this paper
• Comparison of Five-Day Cefdinir Treatment with Ten-Day Low Dose Amoxicillin/Clavulanate Treatment for Acute Otitis Media

  2004cited by this paper
• Diagnosis and management of acute otitis media.

  2004cited by this paper
• Changes in Frequency and Pathogens Causing Acute Otitis Media in 1995–2003

  2004cited by this paper
• Community-Wide Vaccination with the Heptavalent Pneumococcal Conjugate Significantly Alters the Microbiology of Acute Otitis Media

  2004cited by this paper
• Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media.

  2003cited by this paper
• Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002).

  2003cited by this paper
• Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae?

  2003cited by this paper
• Trends in antimicrobial prescribing rates for children and adolescents.

  2002cited by this paper
• National Ambulatory Medical Care Survey: 2000 summary.

  2002cited by this paper
• Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000.

  2002cited by this paper
• Restricted use of antibiotic prophylaxis for recurrent acute otitis media in the era of penicillin non-susceptible Streptococcus pneumoniae.

  2001cited by this paper
• Antimicrobial Resistance among Clinical Isolates ofStreptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995

  2001cited by this paper
• Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

  2001cited by this paper
• Five-day cefdinir course vs. ten-day cefprozil course for treatment of acute otitis media

  2000cited by this paper
• Cefdinir vs. amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children

  2000cited by this paper
• Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric medicaid cohort.

  2000cited by this paper
• Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients

  2000cited by this paper
• Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media

  2000cited by this paper
• Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.

  2000cited by this paper
• Comparative safety and efficacy of cefdinir vs. amoxicillin/clavulanate for treatment of suppurative acute otitis media in children

  2000cited by this paper
• Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.

  1999cited by this paper
• Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children.

  1997cited by this paper
• Cefprozil treatment of persistent and recurrent acute otitis media.

  1997cited by this paper
• A multicenter, double blind comparison of azithromycin and amoxicillin/ clavulanate for the treatment of acute otitis media in children.

  1996cited by this paper
• A multicenter, open label trial of azithromycin vs. amoxicillin/ clavulanate for the management of acute otitis media in children.

  1996cited by this paper
• A multicenter, randomized, open label comparison of azithromycin and amoxicillin/clavulanate in acute otitis media among children attending day care or school.

  1996cited by this paper
• Multicentre comparative study of the efficacy and safety of azithromycin compared with amoxicillin/clavulanic acid in the treatment of paediatric patients with otitis media

  1995cited by this paper
• Otitis media.

  1994cited by this paper
• Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children.

  1993cited by this paper
• Mnlticentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children

  1993cited by this paper
• Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children.

  1993cited by this paper
• Cost Effectiveness of Once‐Daily Oral Antimicrobial Therapy

  1992cited by this paper
• Host factors and early therapeutic response in acute otitis media.

  1991cited by this paper

• Adverse events of cephalosporins in the pediatric population: a comprehensive review

  2025influential citation
• Poor-tasting pediatric medicines: Part 1. A scoping review of their impact on patient acceptability, medication adherence, and treatment outcomes

  2025cites this paper
• Emergent "Bloody Diarrhea" Associated with the Use of Oral Cefdinir in Young Children: A Brief Report and Review of Literature.

  2023cites this paper
• Cefdinir Use in Children

  2014cites this paper
• An evidence-based approach to managing acute otitis media.

  2013cites this paper
• Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline).

  2011cites this paper
• Ototoxicity of topical azithromycin solutions in the guinea pig.

  2010cites this paper
• Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: a systematic literature review.

  2010cites this paper
• Recent Advances in Otitis Media

  2009cites this paper
• Macrolides, Ketolides, and Glyc ylcy clines: Azithromycin, Clarithromycin, Telithromycin,

  2009cites this paper
• Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline.

  2009cites this paper
• Cost and clinical consequence of antibiotic non-adherence in acute exacerbations of chronic bronchitis.

  2009cites this paper
• Optimizing the Management of the Main Acute Infections in Pediatric ORL: Tonsillitis, Sinusitis, Otitis media

  2008cites this paper
• Otimizando o diagnóstico para o tratamento adequado das principais infecções agudas em otorrinopediatria: tonsilite, sinusite e otite média

  2008cites this paper
• Comparison of study designs for acute otitis media trials.

  2008cites this paper
• Oral beta-lactams in the treatment of acute otitis media.

  2007cites this paper
• Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease

  2007cites this paper
• Oral β-lactams in the treatment of acute otitis media

  2007cites this paper
• Oral h-lactams in the treatment of acute otitis media

  2007cites this paper
• A Multicenter, Open Label, Double Tympanocentesis Study of High Dose Cefdinir in Children With Acute Otitis Media at High Risk of Persistent or Recurrent Infection

  2006cites this paper
• Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children*

  2006cites this paper
• Rhinosinusitis in children

  2006cites this paper
• A review of recommended antibiotic therapies with impact on outcomes in acute otitis media and acute bacterial sinusitis.

  2006cites this paper
• Rethinking the total cost of care in AOM and ABS: The impact of improved diagnostic accuracy and antibiotic treatment where high efficacy and adherence are achievable.

  2006cites this paper